Data released today by the European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.
Vytenis Andriukaitis, EU commissioner for health and food safety, said, "The report released today should ring-again-alarm bells. It shows that we are entering into a world where more and more common infections become difficult -- or even sometimes impossible -- to treat. However, ambitious national policies in some countries limiting antimicrobial use have led to a decrease of antimicrobial resistance. So before the alarm bells become a deafening siren, let's make sure that we increasingly act all together, in every country and across the public health, animal health and environment sectors under the One Health approach umbrella."
According to the report, which refers to 2017 data, resistance to fluoroquinolones (such as ciprofloxacin) is so high in Campylobacter bacteria in some countries that these antimicrobials no longer work for the treatment of severe campylobacteriosis cases.
Most countries reported that Salmonella in humans is increasingly resistant to fluoroquinolones. Multi-drug resistance (resistance to three or more antimicrobials) is high in Salmonella found in humans (28.3%) and animals, particularly in S. Typhimurium. In Campylobacter, high to extremely high proportions of bacteria were found to be resistant to ciprofloxacin and tetracyclines. However, combined resistance to critically important antimicrobials was very low to low in Salmonella and Campylobacter from humans and animals and in indicator E. coli from animals.
"Now is the time to turn the tide on antimicrobial resistance if we want to keep antibiotics working," said Mike Catchpole, ECDC's chief scientist. "It's particularly worrying when it comes to combined resistance: even low proportions mean that many thousands of patients across the EU have limited treatment options for severe infections."
Marta Hugas, EFSA's chief scientist, said, "We have seen that when member states have implemented stringent policies, antimicrobial resistance has decreased in animals. Annual reporting by European and national agencies includes noteworthy examples. This should serve as an inspiration for other countries."
The joint report, which presents the data collected from 28 EU member states from humans, pigs and calves under one year of age, confirms the rise in antibiotic resistance already identified in previous years.
In June 2017, the European Commission adopted the EU One Health Action Plan against Antimicrobial Resistance, calling for effective action against this threat and recognising that it needs to be tackled in both human health, animal health and the environment. The prudent use of antimicrobials is essential to limiting the emergence and spread of antibiotic-resistant bacteria in humans and animals.
Source: European Centre for Disease Prevention and Control (ECDC)
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.